vs

Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

CAMDEN NATIONAL CORP is the larger business by last-quarter revenue ($64.3M vs $38.9M, roughly 1.7× CODEXIS, INC.). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs 24.7%, a 9.3% gap on every dollar of revenue. Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs 22.6%).

Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

CAC vs CDXS — Head-to-Head

Bigger by revenue
CAC
CAC
1.7× larger
CAC
$64.3M
$38.9M
CDXS
Higher net margin
CAC
CAC
9.3% more per $
CAC
34.0%
24.7%
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
22.6%
CAC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CAC
CAC
CDXS
CDXS
Revenue
$64.3M
$38.9M
Net Profit
$21.9M
$9.6M
Gross Margin
94.8%
Operating Margin
27.1%
Net Margin
34.0%
24.7%
Revenue YoY
81.3%
Net Profit YoY
-3.0%
192.5%
EPS (diluted)
$1.29
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAC
CAC
CDXS
CDXS
Q1 26
$64.3M
Q4 25
$68.1M
$38.9M
Q3 25
$65.4M
$8.6M
Q2 25
$62.3M
$15.3M
Q1 25
$60.1M
$7.5M
Q4 24
$47.6M
$21.5M
Q3 24
$45.0M
$12.8M
Q2 24
$42.8M
$8.0M
Net Profit
CAC
CAC
CDXS
CDXS
Q1 26
$21.9M
Q4 25
$22.6M
$9.6M
Q3 25
$21.2M
$-19.6M
Q2 25
$14.1M
$-13.3M
Q1 25
$7.3M
$-20.7M
Q4 24
$14.7M
$-10.4M
Q3 24
$13.1M
$-20.6M
Q2 24
$12.0M
$-22.8M
Gross Margin
CAC
CAC
CDXS
CDXS
Q1 26
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Operating Margin
CAC
CAC
CDXS
CDXS
Q1 26
Q4 25
41.5%
27.1%
Q3 25
40.5%
-220.3%
Q2 25
28.5%
-83.9%
Q1 25
10.3%
-271.6%
Q4 24
38.7%
-34.2%
Q3 24
35.2%
-129.0%
Q2 24
34.7%
-284.9%
Net Margin
CAC
CAC
CDXS
CDXS
Q1 26
34.0%
Q4 25
33.1%
24.7%
Q3 25
32.4%
-228.1%
Q2 25
22.6%
-86.6%
Q1 25
12.2%
-274.3%
Q4 24
30.8%
-48.4%
Q3 24
29.1%
-160.8%
Q2 24
28.0%
-285.2%
EPS (diluted)
CAC
CAC
CDXS
CDXS
Q1 26
$1.29
Q4 25
$1.33
$0.13
Q3 25
$1.25
$-0.22
Q2 25
$0.83
$-0.16
Q1 25
$0.43
$-0.25
Q4 24
$1.00
$-0.12
Q3 24
$0.90
$-0.29
Q2 24
$0.81
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAC
CAC
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$514.4M
$40.1M
Stockholders' EquityBook value
$710.0M
$50.5M
Total Assets
$7.0B
$147.8M
Debt / EquityLower = less leverage
0.72×
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAC
CAC
CDXS
CDXS
Q1 26
Q4 25
$78.2M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Total Debt
CAC
CAC
CDXS
CDXS
Q1 26
$514.4M
Q4 25
$40.1M
Q3 25
$39.7M
Q2 25
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Stockholders' Equity
CAC
CAC
CDXS
CDXS
Q1 26
$710.0M
Q4 25
$696.6M
$50.5M
Q3 25
$676.4M
$38.5M
Q2 25
$652.1M
$55.6M
Q1 25
$640.1M
$49.6M
Q4 24
$531.2M
$66.9M
Q3 24
$529.9M
$73.4M
Q2 24
$508.3M
$61.4M
Total Assets
CAC
CAC
CDXS
CDXS
Q1 26
$7.0B
Q4 25
$7.0B
$147.8M
Q3 25
$7.0B
$124.0M
Q2 25
$6.9B
$138.2M
Q1 25
$7.0B
$128.9M
Q4 24
$5.8B
$149.0M
Q3 24
$5.7B
$148.2M
Q2 24
$5.7B
$132.0M
Debt / Equity
CAC
CAC
CDXS
CDXS
Q1 26
0.72×
Q4 25
0.79×
Q3 25
1.03×
Q2 25
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAC
CAC
CDXS
CDXS
Operating Cash FlowLast quarter
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAC
CAC
CDXS
CDXS
Q1 26
Q4 25
$63.9M
$20.1M
Q3 25
$36.1M
$-7.7M
Q2 25
$6.0M
$-18.0M
Q1 25
$1.0M
$-13.8M
Q4 24
$60.9M
$-16.5M
Q3 24
$-14.5M
$-13.0M
Q2 24
$14.5M
$-12.2M
Free Cash Flow
CAC
CAC
CDXS
CDXS
Q1 26
Q4 25
$58.2M
$19.6M
Q3 25
$35.4M
$-7.9M
Q2 25
$4.5M
$-20.5M
Q1 25
$-727.0K
$-15.1M
Q4 24
$55.4M
$-18.2M
Q3 24
$-16.2M
$-14.0M
Q2 24
$13.2M
$-12.6M
FCF Margin
CAC
CAC
CDXS
CDXS
Q1 26
Q4 25
85.5%
50.3%
Q3 25
54.1%
-91.7%
Q2 25
7.3%
-133.6%
Q1 25
-1.2%
-199.6%
Q4 24
116.4%
-85.0%
Q3 24
-36.0%
-109.0%
Q2 24
30.8%
-157.5%
Capex Intensity
CAC
CAC
CDXS
CDXS
Q1 26
Q4 25
8.4%
1.3%
Q3 25
1.1%
2.1%
Q2 25
2.4%
16.4%
Q1 25
2.9%
16.7%
Q4 24
11.7%
8.3%
Q3 24
3.8%
7.8%
Q2 24
3.0%
5.0%
Cash Conversion
CAC
CAC
CDXS
CDXS
Q1 26
Q4 25
2.83×
2.09×
Q3 25
1.70×
Q2 25
0.43×
Q1 25
0.14×
Q4 24
4.15×
Q3 24
-1.11×
Q2 24
1.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CAC
CAC

Net Interest Income$52.4M81%
Noninterest Income$12.0M19%

CDXS
CDXS

Segment breakdown not available.

Related Comparisons